Special Report: Australian biotech company Prescient Therapeutics (ASX:PTX) has announced what’s next for its next-generation gene therapy technology for fighting … Read More
The post Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platform appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.